Company History

Our Chief Executive, David Forrest, following graduating with a Computer Science degree, and several years as a programmer for a software house created FJ Systems Ltd. with Colin Jones (Forrest and Jones).

In the mid 1980’s, following the development of some of the first Electronic Batch Record Systems for ICI Pharmaceuticals (now AstraZeneca), FJ Systems held a niche in the Pharmaceutical Market sector and were part of the founding team that created the Good Automated Manufacturing Practice, GAMP®5 Guide, now edited and issued by the Institute of Pharmaceutical Engineers (ISPE). This is a guide to help ensure how any Critical Computer System, that had an impact on product or patient safety and data, could pass a Regulatory inspection, e.g. FDA, MHRA, i.e. it was Validated.

Having developed FJ Systems for 11 years the business was sold in 1996 with Mr. Forrest being retained to work and grow the business for another 5 years. He was the Director of the Pharmaceutical Division and managed a team of 80, operational and sales staff over 4 offices, which also included two small acquisitions. He later became the Sales Director of 15 staff across multiple industry sectors.

Following the retained period Mr. Forrest started Compliance Control Ltd. in 2006 with a group of industry experts.

Validation and Compliance projects continued with major global Pharmaceutical companies. Compliance Control Ltd. worked for many eastern European countries, including Poland, Macedonia, Serbia, etc.

It was as this time that the ISPE Global Informations Systems Special Interest Group was created to ensure that Computer System Validation aspects of global systems was understood. International regulations were reviewed as part of this project and the idea of cGARD was created, current Global Automated Regulatory Database.

The idea of ComplianceControl Centre came from meetings with many Pharmaceutical companies who wanted visibility over the Quality status of their organisations and thus Compliance Control Ltd. started to change strategy to include Compliance software products along with the Compliance services.

Since 2010 ComplianceControl Centre has been gradually created through prototypes and pilots with industry colleagues and clients, with the particular goal of ensuring that at all times the product remained a GAMP Category 3 system, i.e. minimal configuration, to ensure fast and cost effective client validation.

In particular the recent enhancements in hardware and software, and the introduction of Software As A Service, has provided a real opportunity for to provide software to the SME market. ComplianceControl Centre can now be provided as a completely validated and compliant electronic quality management system to the life science and other similar SME's at a price that they can afford.


Customer References

  • I can certainly recommend Compliance Control as experts in this field and they will add value and deliver on your project. CFO, Major Pharma Company
  • Compliance Controls Consultants brought immediate expertise to our team as part of our drive into the European market. Vice President, Research & Development, Pharma Company
  • We wanted an organization with proven experience ensuring our organization can meet EU regulatory requirements. Business Development Manager, Phama Company
  • I would like to personally express my great appreciation for all your excellent work and great support with the validation of our IT infrastructure and software. Managing Director, Compounding Centre, UK
  • ComplianceControl Centre was selected because it is easy to use, quick to set up, and was a validated, cost effective solution for an organization of our size. We wanted a system that we could rapidly implement. Vice President, Research & Development, Pharma Company
  • Working with Compliance Control Consultants and their software products ComplianceControl Centre and cGARD helped us to understand the regulatory requirements of IT and business systems more clearly. IT Director, Pharma company
  • Using ComplianceControl Centre will help us to ensure that we are always inspection ready, by tracking our critical Quality and Compliance activities. Vice President, Research & Development, Pharma Company
  • It has been a pleasure working with you and your team and I am looking forward to co-operating with your company on similar projects in the future. Managing Director Compounding Centre UK
  • Based on your achievements and delivered results, we have started the process of building up our internal team for continuation of the work started by you. Managing Director, Pharma Company
  • cGARD has become the new rage here ! Sr. Manager, Documentation and Training, Major Pharma Company





© Compliance Control 2014